Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01650506
Brief Title: Study of Erlotinib and Metformin in Triple Negative Breast Cancer

First Submitted : July 24, 2012
First Submitted that Met QC Criteria : July 25, 2012
First Posted : July 26, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 28, 2017
Last Update Posted : August 30, 2017